Combining pulsed electric field ablation with SBRT for lung tumors did not cause clinically meaningful declines in pulmonary function or quality of life at 3 months.
Does the addition of pulsed electric field ablation to SBRT affect pulmonary function or health-related quality of life in patients with lung tumors?
The addition of pulsed electric field ablation to SBRT for lung tumors does not appear to cause clinically meaningful declines in pulmonary function or quality of life at 3 months.
Absolute Event Rate: 0% vs 0%
In this small pilot study, no clinically meaningful declines in pulmonary function or patient-reported quality of life were observed at 3 months following combination therapy.
Harris et al. (Thu,) reported a other. Combining pulsed electric field ablation with SBRT for lung tumors did not cause clinically meaningful declines in pulmonary function or quality of life at 3 months.